During the Covid pandemic, Xerum became nationally known for its self sampling and one of the world’s most sensitive antibody test. Now the Umeå company has been nominated for the prestigious MedTech4Health Innovation Award.
Xerum will, on behalf of the Public Health Agency, measure the presence of antibodies in the population against SARS-CoV-2, the virus that causes covid-19 in Sweden.
“We’re delighted that our antibody test is proving useful”, says Julia Wigren Byström, CEO at Xerum.
Xerum assigned by Swedish Public Health Agency to measure number of Swedes with antibodies against SARS-CoV-2
Umeå-based Xerum launched a home testing kit in March that detects antibodies against SARS-CoV-2 – the virus that causes Covid-19. Uptake of the kits was strong, and now the company has been given an important assignment by Sweden’s Folkhälsomyndigheten (the Swedish Public Health Agency).
“This is amazing news”, says Julia Wigren Byström, CEO of Xerum. “We will be responsible for the distribution and analysis of our self-sampling kits as part of a large study being conducted by the Swedish Public Health Agency to measure the number of people in the country who have developed antibodies”.
From March 1st Västerbotten will become the first region in Sweden to offer its residents home testing kits that can detect antibodies for COVID-19.